0001415889-22-002615.txt : 20220304
0001415889-22-002615.hdr.sgml : 20220304
20220304200519
ACCESSION NUMBER: 0001415889-22-002615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220302
FILED AS OF DATE: 20220304
DATE AS OF CHANGE: 20220304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brophy Michael Burkes
CENTRAL INDEX KEY: 0001697362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 22715939
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-03042022_080301.xml
X0306
4
2022-03-02
0001604821
Natera, Inc.
NTRA
0001697362
Brophy Michael Burkes
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
false
true
false
false
CHIEF FINANCIAL OFFICER
Common Stock
2022-03-02
4
A
0
7353
0
A
78345
D
Common Stock
2022-03-04
4
F
0
1938
58.3895
D
76407
D
On April 12, 2019, the Reporting Person was granted performance-based Restricted Stock Units (the "RSUs") covering 14,706 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On March 2, 2022, the milestones were satisfied for the vesting of RSUs covering the remaining 7,353 shares of Common Stock.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.6826 to $58.4006 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact
2022-03-04